| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.9 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0083 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |